Surface-Modified Nanodrug Carriers for Brain Cancer Treatment
- 1 December 2020
- book chapter
- Published by Springer Nature
- p. 127-144
Abstract
No abstract availableKeywords
This publication has 100 references indexed in Scilit:
- Cdc42 and the Guanine Nucleotide Exchange Factors Ect2 and Trio Mediate Fn14-Induced Migration and Invasion of Glioblastoma CellsMolecular Cancer Research, 2012
- TWEAK/Fn14 pathway: an immunological switch for shaping tissue responsesImmunological Reviews, 2011
- Delivering nanomedicine to solid tumorsNature Reviews Clinical Oncology, 2010
- EGFRvIII Antibody–Conjugated Iron Oxide Nanoparticles for Magnetic Resonance Imaging–Guided Convection-Enhanced Delivery and Targeted Therapy of GlioblastomaCancer Research, 2010
- The Pathobiology of Glioma TumorsAnnual Review of Pathology: Mechanisms of Disease, 2010
- Cilengitide: an integrin-targeting arginine–glycine–aspartic acid peptide with promising activity for glioblastoma multiformeExpert Opinion on Investigational Drugs, 2008
- The TWEAK–Fn14 cytokine–receptor axis: discovery, biology and therapeutic targetingNature Reviews Drug Discovery, 2008
- Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trialActa Neurochirurgica, 2006
- Radiotherapy plus Concomitant and Adjuvant Temozolomide for GlioblastomaNew England Journal of Medicine, 2005
- The safety of interstitial chemotherapy with BCNU-loaded polymer followed by radiation therapy in the treatment of newly diagnosed malignant gliomas: Phase I trialJournal of Neuro-Oncology, 1995